Novel tetracyclic spirobenzazepine compounds of the formula ##STR1## or a pharmaceutically-acceptable salt, amide or ester thereof, which are dopamine D-1 receptor antagonists useful for treating dopamine-related neurological and psychological disorders, cognitive impairment, attention deficit disorders and addictive behavior disorders.
新型四环螺合苯并
哌啶类化合物的
化学式为##STR1##或其药用盐、酰胺或酯,这些化合物是
多巴胺D-1受体拮抗剂,用于治疗与
多巴胺相关的神经和心理障碍、认知障碍、注意力缺陷障碍和成瘾行为障碍。